Company intelligence / Profile preview

Shandong Granvac Biopharmaceutical

Jinan, Shandong, China

Ownership: Private
Development stage: Other

Overview

Shandong Granvac Biopharmaceutical is a China-based biotechnology company specializing in the research, development, and manufacturing of innovative vaccines and therapeutic biologics. The company leverages advanced technology platforms, including mRNA and recombinant protein systems, to address significant public health challenges such as COVID-19 and HPV. Granvac operates integrated facilities for R&D and large-scale production, aiming to provide high-quality, affordable immunization solutions. Their pipeline includes several candidates in various stages of clinical development, supported by a team of experts in immunology and molecular biology.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicmRNA-based drugsRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Shandong Granvac Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Granvac Biopharmaceutical.

Explore the full profile